$ACHR
Archer Aviation Inc. Stock $achr

$achr Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000162828024007963 Filed on February 29, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$27.70M	$167.9M	$165.1M
YoY Change	-37.19%	1.7%	-6.34%
% of Gross Profit
Research & Development	$77.50M	$276.4M	$171.5M
YoY Change	30.91%	61.17%	166.72%
% of Gross Profit
Depreciation & Amortization	$2.300M	$5.800M	$3.100M
YoY Change	35.29%	87.1%	138.46%
% of Gross Profit
Operating Expenses	$107.3M	$446.9M	$347.4M
YoY Change	-0.74%	28.64%	-3.04%
Operating Profit		-$446.9M	-$347.4M
YoY Change		28.64%	-3.04%
Interest Expense	$5.600M	$16.40M	$2.300M
YoY Change	700.0%	613.04%	130.0%
% of Operating Profit
Other Income/Expense, Net	-$7.200M	-$26.90M	$27.80M
YoY Change	-160.0%	-196.76%	162.26%
Pretax Income	-$108.9M	-$457.4M	-$317.3M
YoY Change	14.15%	44.15%	-8.77%
Income Tax	$200.0K	$500.0K	$0.00
% Of Pretax Income
Net Earnings	-$109.1M	-$457.9M	-$317.3M
YoY Change	14.36%	44.31%	-8.77%
Net Earnings / Revenue
Basic Earnings Per Share		-$1.69	-$1.32
Diluted Earnings Per Share	-$0.36	-$1.69	-$1.32
COMMON SHARES
Basic Shares Outstanding		270.4M shares	240.5M shares
Diluted Shares Outstanding		270.4M shares	240.5M shares

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$464.6M	$464.6M	$531.2M
YoY Change	-12.54%	-12.54%	-28.88%
Cash & Equivalents	$464.6M	$464.6M	$69.40M
Short-Term Investments	$0.00	$0.00	$461.8M
Other Short-Term Assets	$800.0K	$15.60M	$14.30M
YoY Change	-50.0%	9.09%	81.01%
Inventory
Prepaid Expenses	$7.900M
Receivables
Other Receivables
Total Short-Term Assets	$480.2M	$480.2M	$545.5M
YoY Change	-11.97%	-11.97%	-27.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$57.60M	$66.50M	$23.40M
YoY Change	400.87%	184.19%	125.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$7.200M	$7.200M	$4.500M
YoY Change	60.0%	60.0%	66.67%
Total Long-Term Assets	$74.10M	$74.10M	$28.30M
YoY Change	161.84%	161.84%	108.09%
TOTAL ASSETS
Total Short-Term Assets	$480.2M	$480.2M	$545.5M
Total Long-Term Assets	$74.10M	$74.10M	$28.30M
Total Assets	$554.3M	$554.3M	$573.8M
YoY Change	-3.4%	-3.4%	-25.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.30M	$14.30M	$3.600M
YoY Change	297.22%	297.22%	5.88%
Accrued Expenses	$94.60M	$94.60M	$40.40M
YoY Change	134.16%	134.16%	162.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$9.300M
YoY Change	-100.0%	-100.0%	-2.11%
Total Short-Term Liabilities	$114.0M	$114.0M	$53.30M
YoY Change	113.88%	113.88%	88.34%
LONG-TERM LIABILITIES
Long-Term Debt	$7.200M	$7.200M	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$12.90M	$66.00M	$27.20M
YoY Change	17.27%	142.65%	-14.73%
Total Long-Term Liabilities	$20.10M	$73.20M	$27.20M
YoY Change	82.73%	169.12%	-33.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$114.0M	$114.0M	$53.30M
Total Long-Term Liabilities	$20.10M	$73.20M	$27.20M
Total Liabilities	$187.2M	$187.2M	$80.50M
YoY Change	132.55%	132.55%	15.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.149B
YoY Change	66.28%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$367.1M	$367.1M	$493.3M
YoY Change
Total Liabilities & Shareholders Equity	$554.3M	$554.3M	$573.8M
YoY Change	-3.4%	-3.4%	-25.33%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	-$109.1M	-$457.9M	-$317.3M
YoY Change	14.36%	44.31%	-8.77%
Depreciation, Depletion And Amortization	$2.300M	$5.800M	$3.100M
YoY Change	35.29%	87.1%	138.46%
Cash From Operating Activities	-$84.00M	-$271.6M	-$200.4M
YoY Change	25.0%	35.53%	84.87%
INVESTING ACTIVITIES
Capital Expenditures	$9.000M	$44.30M	$6.900M
YoY Change	172.73%	542.03%	97.14%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$465.0M	-$457.4M
YoY Change	-100.0%	-201.66%
Cash From Investing Activities	-$9.000M	$420.7M	-$464.3M
YoY Change	-133.46%	-190.61%	13165.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$95.00M
YoY Change
Debt Paid & Issued, Net		$10.00M	$10.00M
YoY Change		0.0%
Cash From Financing Activities	95.80M	$250.1M	-$9.900M
YoY Change	-3521.43%	-2626.26%	-101.2%
NET CHANGE
Cash From Operating Activities	-84.00M	-$271.6M	-$200.4M
Cash From Investing Activities	-9.000M	$420.7M	-$464.3M
Cash From Financing Activities	95.80M	$250.1M	-$9.900M
Net Change In Cash	2.800M	$399.2M	-$674.6M
YoY Change	-106.5%	-159.18%	-194.97%
FREE CASH FLOW
Cash From Operating Activities	-$84.00M	-$271.6M	-$200.4M
Capital Expenditures	$9.000M	$44.30M	$6.900M
Free Cash Flow	-$93.00M	-$315.9M	-$207.3M
YoY Change	31.91%	52.39%	85.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001824502
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39668
CY2023	dei	Entity Registrant Name EntityRegistrantName	Archer Aviation Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2730902
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	San Jose
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95134
CY2023	dei	City Area Code CityAreaCode	650
CY2023	dei	Local Phone Number LocalPhoneNumber	272-3233
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	839900000	usd
CY2023	dei	Auditor Firm AuditorFirmId	238
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	464600000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.69
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-457900000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	800000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-800000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-457100000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-318100000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-347800000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	35900000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	4900000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	240476894	shares
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	36700000	usd
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	190 West Tasman Drive
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Auditor Location AuditorLocation	Irvine, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	464600000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69400000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69400000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	6900000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	6900000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	2900000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	2900000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	461800000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7900000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9800000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	800000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1600000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	480200000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	545500000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57600000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11500000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	400000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	400000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8900000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11900000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7200000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4500000	usd
CY2023Q4	us-gaap	Assets Assets	554300000	usd
CY2022Q4	us-gaap	Assets Assets	573800000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14300000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3600000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2800000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3700000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	9300000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	96900000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	114000000.0	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	53300000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	7200000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13200000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9200000	usd
CY2023Q4	achr	Warrant Liabilities Noncurrent WarrantLiabilitiesNoncurrent	39900000	usd
CY2022Q4	achr	Warrant Liabilities Noncurrent WarrantLiabilitiesNoncurrent	7000000.0	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12900000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11000000.0	usd
CY2023Q4	us-gaap	Liabilities Liabilities	187200000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	80500000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1515900000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1185000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1148800000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-690900000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-800000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	367100000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	493300000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	554300000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	573800000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	276400000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	171500000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	64300000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	168400000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	165100000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	176700000	usd
CY2023	achr	Other Warrant Expense OtherWarrantExpense	2100000	usd
CY2022	achr	Other Warrant Expense OtherWarrantExpense	10800000	usd
CY2021	achr	Other Warrant Expense OtherWarrantExpense	117300000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	446900000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	347400000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	358300000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-446900000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-347400000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-358300000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	900000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-26900000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	27800000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10600000	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	16400000	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	2300000	usd
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1000000.0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-457400000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-317300000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-347800000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	500000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-457900000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-317300000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-347800000	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.69
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.32
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.32
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.14
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.14
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	270408132	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	270408132	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	240476894	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110836238	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110836238	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-317300000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-347800000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	118100000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	500000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	124300000	usd
CY2021	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	100000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5500000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	162300000	usd
CY2021	achr	Stock Issued During Period Value Pipe Financing StockIssuedDuringPeriodValuePIPEFinancing	600000000.0	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-347800000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	698900000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	71300000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	400000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	14100000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	26700000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-317300000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-800000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	493300000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11600000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-6600000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	200000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	46000000.0	usd
CY2023	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	0	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3500000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2900000	usd
CY2023	achr	Stock Issued During Period Value Stock Purchase Agreement StockIssuedDuringPeriodValueStockPurchaseAgreement	89600000	usd
CY2023	achr	Stock Issued During Period Value At The Market Offering StockIssuedDuringPeriodValueAtTheMarketOffering	19500000	usd
CY2023	achr	Stock Issued During Period Value Pipe Financing StockIssuedDuringPeriodValuePIPEFinancing	139000000.0	usd
CY2023	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	6500000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	32200000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-457900000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	800000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	367100000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-457900000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-317300000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-347800000	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	4400000	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1300000	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	700000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	500000	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	200000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	45200000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	102800000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	123600000	usd
CY2023	achr	Fair Value Adjustment Of Warrants And Other Warrant Costs FairValueAdjustmentOfWarrantsAndOtherWarrantCosts	32900000	usd
CY2022	achr	Fair Value Adjustment Of Warrants And Other Warrant Costs FairValueAdjustmentOfWarrantsAndOtherWarrantCosts	-22900000	usd
CY2021	achr	Fair Value Adjustment Of Warrants And Other Warrant Costs FairValueAdjustmentOfWarrantsAndOtherWarrantCosts	-10400000	usd
CY2023	achr	Gain Loss On Issuance Of Common Stock GainLossOnIssuanceOfCommonStock	3600000	usd
CY2022	achr	Gain Loss On Issuance Of Common Stock GainLossOnIssuanceOfCommonStock	0	usd
CY2021	achr	Gain Loss On Issuance Of Common Stock GainLossOnIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	3800000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	4600000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1700000	usd
CY2023	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	17500000	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	2900000	usd
CY2021	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	7000000.0	usd
CY2023	achr	Other Warrant Expense OtherWarrantExpense	2100000	usd
CY2022	achr	Other Warrant Expense OtherWarrantExpense	10800000	usd
CY2021	achr	Other Warrant Expense OtherWarrantExpense	117300000	usd
CY2023	achr	Technology And Dispute Resolution Agreements Expense TechnologyAndDisputeResolutionAgreementsExpense	70300000	usd
CY2022	achr	Technology And Dispute Resolution Agreements Expense TechnologyAndDisputeResolutionAgreementsExpense	0	usd
CY2021	achr	Technology And Dispute Resolution Agreements Expense TechnologyAndDisputeResolutionAgreementsExpense	0	usd
CY2023	us-gaap	Interest Income Short Term Investment Increase Decrease InterestIncomeShortTermInvestmentIncreaseDecrease	0	usd
CY2022	us-gaap	Interest Income Short Term Investment Increase Decrease InterestIncomeShortTermInvestmentIncreaseDecrease	500000	usd
CY2021	us-gaap	Interest Income Short Term Investment Increase Decrease InterestIncomeShortTermInvestmentIncreaseDecrease	0	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	2300000	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	900000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1900000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2200000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	6800000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-800000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1200000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	300000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	5000000.0	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-400000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2700000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9200000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-100000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-800000	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2300000	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	15600000	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	12100000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	2400000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3400000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1900000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1600000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	10100000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-271600000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-200400000	usd
CY2023	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	487400000	usd
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	465000000.0	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-674600000	usd
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	30000000.0	usd
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44300000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6900000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	420700000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-464300000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3500000	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	7500000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	20000000.0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	10000000.0	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	10000000.0	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	300000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	200000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3500000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	145000000.0	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	600000000.0	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	6000000.0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2023	achr	Proceeds From Issuance At The Market Offering ProceedsFromIssuanceAtTheMarketOffering	20700000	usd
CY2022	achr	Proceeds From Issuance At The Market Offering ProceedsFromIssuanceAtTheMarketOffering	0	usd
CY2021	achr	Proceeds From Issuance At The Market Offering ProceedsFromIssuanceAtTheMarketOffering	0	usd
CY2023	achr	Payments Of Offering Costs At The Market Offering PaymentsOfOfferingCostsAtTheMarketOffering	1200000	usd
CY2022	achr	Payments Of Offering Costs At The Market Offering PaymentsOfOfferingCostsAtTheMarketOffering	0	usd
CY2021	achr	Payments Of Offering Costs At The Market Offering PaymentsOfOfferingCostsAtTheMarketOffering	0	usd
CY2023	achr	Proceeds From Recapitalization Transaction ProceedsFromRecapitalizationTransaction	0	usd
CY2022	achr	Proceeds From Recapitalization Transaction ProceedsFromRecapitalizationTransaction	0	usd
CY2021	achr	Proceeds From Recapitalization Transaction ProceedsFromRecapitalizationTransaction	257600000	usd
CY2023	achr	Payments For Reverse Recapitalization Transaction Costs PaymentsForReverseRecapitalizationTransactionCosts	0	usd
CY2022	achr	Payments For Reverse Recapitalization Transaction Costs PaymentsForReverseRecapitalizationTransactionCosts	0	usd
CY2021	achr	Payments For Reverse Recapitalization Transaction Costs PaymentsForReverseRecapitalizationTransactionCosts	55800000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	100000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	500000	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	100000	usd
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	2900000	usd
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	95000000.0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	250100000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9900000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	822200000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	399200000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	710300000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72300000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	746900000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36600000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	471500000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72300000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	746900000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	800000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1500000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	700000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	10800000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3100000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2100000	usd
CY2023	achr	Allocation Of Debt Proceeds To Stock Warrants AllocationOfDebtProceedsToStockWarrants	0	usd
CY2022	achr	Allocation Of Debt Proceeds To Stock Warrants AllocationOfDebtProceedsToStockWarrants	0	usd
CY2021	achr	Allocation Of Debt Proceeds To Stock Warrants AllocationOfDebtProceedsToStockWarrants	1200000	usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	61500000	usd
CY2023	achr	Pipe Financing Issuance Costs Settled With The Issuance PIPEFinancingIssuanceCostsSettledWithTheIssuance	0	usd
CY2022	achr	Pipe Financing Issuance Costs Settled With The Issuance PIPEFinancingIssuanceCostsSettledWithTheIssuance	0	usd
CY2021	achr	Pipe Financing Issuance Costs Settled With The Issuance PIPEFinancingIssuanceCostsSettledWithTheIssuance	7000000.0	usd
CY2023	achr	Recapitalization Transaction Costs Settled With The Issuance Of Class A Common Stock RecapitalizationTransactionCostsSettledWithTheIssuanceOfClassACommonStock	0	usd
CY2022	achr	Recapitalization Transaction Costs Settled With The Issuance Of Class A Common Stock RecapitalizationTransactionCostsSettledWithTheIssuanceOfClassACommonStock	0	usd
CY2021	achr	Recapitalization Transaction Costs Settled With The Issuance Of Class A Common Stock RecapitalizationTransactionCostsSettledWithTheIssuanceOfClassACommonStock	8100000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	Organization and Nature of Business<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Organization and Nature of Business</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Archer Aviation Inc. (the “Company”), a Delaware corporation, with its headquarters located in San Jose, California, is an aerospace company. The Company is designing and developing electric vertical takeoff and landing (“eVTOL”) aircraft for use in urban air mobility (“UAM”) networks. The Company’s mission is to unlock the skies, freeing everyone to reimagine how they move and spend time.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company’s Planned Lines of Business </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of all necessary Federal Aviation Administration (“FAA”) certifications and any other government approvals necessary for the Company to manufacture and operate its aircraft, the Company intends to operate two complementary lines of business. The Company’s core focus is direct-to-consumer offerings (“Archer UAM”) with its secondary focus being business-to-business offerings (“Archer Direct”).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Archer UAM</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company plans to operate its own UAM ecosystem initially in select major cities. The Company’s UAM ecosystem will operate using its eVTOL aircraft which is currently in development.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Archer Direct</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also plans to selectively sell a certain amount of its eVTOL aircraft along with ancillary products and services to third parties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combination</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 16, 2021 (the “Closing Date”), Archer Aviation, Inc., a Delaware corporation (prior to the closing of the Business Combination (as defined below), “Legacy Archer”), Atlas Crest Investment Corp., a Delaware corporation (“Atlas”), and Artemis Acquisition Sub Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Atlas (“Merger Sub”), consummated the closing of the transactions contemplated by the Business Combination Agreement, dated February 10, 2021, as amended and restated on July 29, 2021, by and among Atlas, Legacy Archer and Merger Sub (the “Business Combination Agreement”), following approval at a special meeting of the stockholders of Atlas held on September 14, 2021 (the “Special Meeting”). Unless otherwise specified or unless the context otherwise requires, references in these notes to Legacy Archer refer to Archer prior to the Business Combination and references in these notes to “New Archer” refer to Archer following the Business Combination.</span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Business Combination Agreement, a business combination of Legacy Archer and Atlas was effected by the merger of Merger Sub with and into Legacy Archer, with Legacy Archer surviving the merger (the “Surviving Entity”) as a wholly-owned subsidiary of Atlas (the “Merger,” and, collectively with the other transactions described in the Business Combination Agreement, the “Business Combination”). Following the consummation of the Merger on the Closing Date, the Surviving Entity changed its name from Archer Aviation, Inc. to Archer Aviation Operating Corp., and Atlas changed its name from Atlas Crest Investment Corp. to Archer Aviation Inc. and it became the successor registrant with the U.S. Securities and Exchange Commission (the “SEC”). Prior to the closing of the Business Combination, the Class A common stock and public warrants of Atlas were listed on the New York Stock Exchange (“NYSE”) under the symbols “ACIC” and “ACIC WS,” respectively. New Archer Class A common stock and public warrants are currently listed on the NYSE under the symbols “ACHR” and “ACHR WS,” respectively.</span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements included in this report reflect (i) the historical operating results of Legacy Archer prior to the Business Combination; (ii) the combined results of Atlas and Legacy Archer following the closing of the Business Combination; (iii) the assets and liabilities of Legacy Archer at their historical cost; and (iv) the Company’s equity structure for all periods presented.</span></div>
CY2023	achr	Number Of Lines Of Business NumberOfLinesOfBusiness	2	lineofbusiness
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1148800000	usd
CY2023	achr	Proceeds From Private Placement And Recapitalization Transaction ProceedsFromPrivatePlacementAndRecapitalizationTransaction	801800000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	464600000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	464600000	usd
CY2023Q4	achr	Cash Cash Equivalents And Available For Sale Debt Securities CashCashEquivalentsAndAvailableForSaleDebtSecurities	339600000	usd
CY2022Q4	achr	Cash Cash Equivalents And Available For Sale Debt Securities Amortized Cost CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost	468700000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	800000	usd
CY2022Q4	achr	Cash Cash Equivalents And Available For Sale Debt Securities CashCashEquivalentsAndAvailableForSaleDebtSecurities	467900000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. </span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management evaluates its estimates, including those related to the: (i) realization of deferred tax assets and estimates of tax liabilities, (ii) fair value of debt, (iii) fair value of share-based payments, (iv) valuation of leased assets and liabilities, and (v) estimated useful lives of long-lived assets. These estimates are based on historical data and experience, as well as various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Such estimates often require the selection of appropriate valuation methodologies and models and may involve significant judgment in evaluating ranges of assumptions and financial inputs. Actual results may differ from those estimates under different assumptions, financial inputs, or circumstances.</span></div>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	464600000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	464600000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69400000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69400000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	6900000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	6900000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	2900000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	2900000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	471500000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72300000	usd
CY2023Q4	achr	Cash Cash Equivalents And Available For Sale Debt Securities Amortized Cost CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost	339600000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2021	us-gaap	Depreciation Depreciation	1300000	usd
CY2023	achr	Warrant Liability Term WarrantLiabilityTerm	P2Y8M15D
CY2022	achr	Warrant Liability Term WarrantLiabilityTerm	P3Y8M15D
CY2023	achr	Accrued Technology And Dispute Resolution Agreements Liability Term AccruedTechnologyAndDisputeResolutionAgreementsLiabilityTerm	P0Y1M9D
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-32900000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-23300000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2023	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	400000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	400000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	6400000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	3700000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10800000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10000000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	89514569	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	81629009	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	80087974	shares
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021Q3	achr	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.00656519
CY2021Q3	achr	Proceeds From Recapitalization Transaction ProceedsFromRecapitalizationTransaction	257600000	usd
CY2021Q3	achr	Proceeds From Reverse Recapitalization Net Of Redemptions ProceedsFromReverseRecapitalizationNetOfRedemptions	242400000	usd
CY2021Q3	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	1	shares
CY2021Q3	achr	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	201800000	usd
CY2021Q3	achr	Warrant Liability WarrantLiability	39500000	usd
CY2021Q3	achr	Reverse Recapitalization Net ReverseRecapitalizationNet	162300000	usd
CY2021Q3	achr	Reverse Recapitalization Contingent Consideration Equity Earnout Period ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod	P3Y
CY2021Q3	achr	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTrigger	12.00
CY2021Q3	achr	Reverse Recapitalization Contingent Consideration Equity Threshold Trading Days ReverseRecapitalizationContingentConsiderationEquityThresholdTradingDays	10	trading_day
CY2021Q3	achr	Reverse Recapitalization Contingent Consideration Equity Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationEquityThresholdConsecutiveTradingDays	20	trading_day
CY2021Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	60260483	shares
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	60000000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2021Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	600000000	usd
CY2021Q3	achr	Stock Issued During Period Shares Business Combination And Pipe Financing Fees StockIssuedDuringPeriodSharesBusinessCombinationAndPIPEFinancingFees	1512500	shares
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4738344	shares
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	2540925	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59851643	shares
CY2021Q3	achr	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	64884120	shares
CY2021Q3	achr	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	101269813	shares
CY2021Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	10004612	shares
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	61512500	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	232638568	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	24666667	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q3	achr	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	81800000	usd
CY2021Q3	achr	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	10900000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	55800000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	67000000.0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15100000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9400000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3600000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57600000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11500000	usd
CY2023	us-gaap	Depreciation Depreciation	5800000	usd
CY2022	us-gaap	Depreciation Depreciation	3100000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	9500000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	17200000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16700000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7800000	usd
CY2023Q4	achr	Accrued Parts And Materials AccruedPartsAndMaterials	12100000	usd
CY2022Q4	achr	Accrued Parts And Materials AccruedPartsAndMaterials	5200000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1400000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	300000	usd
CY2023Q4	achr	Accrued Capital Expenditures AccruedCapitalExpenditures	9200000	usd
CY2022Q4	achr	Accrued Capital Expenditures AccruedCapitalExpenditures	2900000	usd
CY2023Q4	achr	Accrued Cloud Computing Implementation Costs AccruedCloudComputingImplementationCosts	300000	usd
CY2022Q4	achr	Accrued Cloud Computing Implementation Costs AccruedCloudComputingImplementationCosts	2000000.0	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	0	usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	200000	usd
CY2023Q4	achr	Accrued Technology And Dispute Resolution Agreements Liability Fair Value Disclosure AccruedTechnologyAndDisputeResolutionAgreementsLiabilityFairValueDisclosure	44000000.0	usd
CY2022Q4	achr	Accrued Technology And Dispute Resolution Agreements Liability Fair Value Disclosure AccruedTechnologyAndDisputeResolutionAgreementsLiabilityFairValueDisclosure	0	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	3700000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	1100000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	96900000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	36700000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	7200000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	9300000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	9300000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7200000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2023Q4	achr	Lessee Leasehold Improvement Allowance LesseeLeaseholdImprovementAllowance	700000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	100000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	300000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	300000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	6800000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	7500000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	5700000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	5800000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	2100000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	600000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	200000	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2023	us-gaap	Lease Cost LeaseCost	6300000	usd
CY2022	us-gaap	Lease Cost LeaseCost	6000000.0	usd
CY2021	us-gaap	Lease Cost LeaseCost	2100000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P58M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P46M
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1474
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1378
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5500000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5100000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4600000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2200000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2200000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4400000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	24000000.0	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	23300000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7300000	usd
CY2023Q4	achr	Lessee Operating Lease Liability To Be Paid Net LesseeOperatingLeaseLiabilityToBePaidNet	16000000.0	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	5000000.0	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	4300000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1900000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	600000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	11700000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3600000	usd
CY2023	achr	General And Administrative Expense Noncash Charges GeneralAndAdministrativeExpenseNoncashCharges	70300000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	1	shares
CY2023	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	1	shares
CY2023	achr	Common Stock Conversion Terms Period Following That A Founder Ceases Services To The Company CommonStockConversionTermsPeriodFollowingThatAFounderCeasesServicesToTheCompany	P12M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	achr	Amount Reclassified From Legal Expense To Stock Based Compensation Expense AmountReclassifiedFromLegalExpenseToStockBasedCompensationExpense	11600000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45200000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	102800000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	123600000	usd
CY2021Q1	achr	Purchase Agreement Number Of Aircraft PurchaseAgreementNumberOfAircraft	200	aircraft
CY2021Q1	achr	Purchase Agreement Option To Purchase Additional Aircraft PurchaseAgreementOptionToPurchaseAdditionalAircraft	100	aircraft
CY2021Q1	achr	Valuation Of Common Stock Per Share ValuationOfCommonStockPerShare	13.35
CY2021Q1	achr	Valuation Of Common Stock Pwerm Weighted Percentage ValuationOfCommonStockPWERMWeightedPercentage	0.80
CY2021Q1	achr	Valuation Of Common Stock Opm Weighted Percentage ValuationOfCommonStockOPMWeightedPercentage	0.20
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2021Q1	achr	Class Of Warrant Or Right Grant Date Fair Value ClassOfWarrantOrRightGrantDateFairValue	13.35
CY2021	achr	Other Warrant Expense OtherWarrantExpense	117300000	usd
CY2021	achr	Class Of Warrant Or Right Vested During The Period ClassOfWarrantOrRightVestedDuringThePeriod	8845058	shares
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3600000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-458700000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-317300000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-347800000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1300000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-457400000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-317300000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-347800000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	500000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.027
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.025
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.026
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.002
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.002
CY2023	achr	Effective Income Tax Rate Reconciliation Warrant Expense Percent EffectiveIncomeTaxRateReconciliationWarrantExpensePercent	-0.016
CY2022	achr	Effective Income Tax Rate Reconciliation Warrant Expense Percent EffectiveIncomeTaxRateReconciliationWarrantExpensePercent	0.008
CY2021	achr	Effective Income Tax Rate Reconciliation Warrant Expense Percent EffectiveIncomeTaxRateReconciliationWarrantExpensePercent	-0.065
CY2023	achr	Effective Income Tax Rate Reconciliation Section162m Limitation Percent EffectiveIncomeTaxRateReconciliationSection162mLimitationPercent	0.001
CY2022	achr	Effective Income Tax Rate Reconciliation Section162m Limitation Percent EffectiveIncomeTaxRateReconciliationSection162mLimitationPercent	-0.047
CY2021	achr	Effective Income Tax Rate Reconciliation Section162m Limitation Percent EffectiveIncomeTaxRateReconciliationSection162mLimitationPercent	-0.069
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.007
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.002
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.044
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.049
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.013
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.212
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.236
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.115
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	84100000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	43400000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	12400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1500000	usd
CY2023Q4	achr	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	3500000	usd
CY2022Q4	achr	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	3300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1900000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3700000	usd
CY2023Q4	achr	Deferred Tax Asset Warrants DeferredTaxAssetWarrants	6000000.0	usd
CY2022Q4	achr	Deferred Tax Asset Warrants DeferredTaxAssetWarrants	2500000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	77800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	51700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	41700000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	21100000	usd
CY2023Q4	achr	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	3800000	usd
CY2022Q4	achr	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	4700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	700000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	900000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	231900000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	132800000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	226300000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	129700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3100000	usd
CY2023Q4	achr	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	3700000	usd
CY2022Q4	achr	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1900000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	3100000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5600000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	226300000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	96600000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	82600000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	39900000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2000000.0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	300000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	2000000.0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	300000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1200000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1500000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	500000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2000000.0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
achr-20231231_cal.xml	Edgar Link	unprocessable
0001628280-24-007963-index-headers.html	Edgar Link	pending
0001628280-24-007963-index.html	Edgar Link	pending
0001628280-24-007963.txt	Edgar Link	pending
0001628280-24-007963-xbrl.zip	Edgar Link	pending
achr-10xkxex41180488432.htm	Edgar Link	pending
achr-20231231.htm	Edgar Link	pending
achr-20231231.xsd	Edgar Link	pending
ex971.htm	Edgar Link	pending
exhibit1029.htm	Edgar Link	pending
exhibit1029001.jpg	Edgar Link	pending
exhibit1029002.jpg	Edgar Link	pending
exhibit1029003.jpg	Edgar Link	pending
exhibit1029004.jpg	Edgar Link	pending
exhibit1029005.jpg	Edgar Link	pending
exhibit1029006.jpg	Edgar Link	pending
exhibit1029007.jpg	Edgar Link	pending
exhibit1029008.jpg	Edgar Link	pending
exhibit1029009.jpg	Edgar Link	pending
exhibit1029010.jpg	Edgar Link	pending
exhibit1029011.jpg	Edgar Link	pending
exhibit1029012.jpg	Edgar Link	pending
exhibit1029013.jpg	Edgar Link	pending
exhibit1029014.jpg	Edgar Link	pending
exhibit1029015.jpg	Edgar Link	pending
exhibit1029016.jpg	Edgar Link	pending
exhibit1029017.jpg	Edgar Link	pending
exhibit1029018.jpg	Edgar Link	pending
achr-20231231_def.xml	Edgar Link	unprocessable
achr-20231231_lab.xml	Edgar Link	unprocessable
achr-20231231_pre.xml	Edgar Link	unprocessable
achr-20231231_htm.xml	Edgar Link	completed
exhibit1029019.jpg	Edgar Link	pending
exhibit1029020.jpg	Edgar Link	pending
exhibit1029021.jpg	Edgar Link	pending
exhibit1029022.jpg	Edgar Link	pending
exhibit1029023.jpg	Edgar Link	pending
exhibit1029024.jpg	Edgar Link	pending
exhibit1029025.jpg	Edgar Link	pending
exhibit1029026.jpg	Edgar Link	pending
exhibit1029027.jpg	Edgar Link	pending
exhibit1029028.jpg	Edgar Link	pending
exhibit1029029.jpg	Edgar Link	pending
exhibit1029030.jpg	Edgar Link	pending
exhibit1029031.jpg	Edgar Link	pending
exhibit1029032.jpg	Edgar Link	pending
exhibit1029033.jpg	Edgar Link	pending
exhibit1029034.jpg	Edgar Link	pending
exhibit1029035.jpg	Edgar Link	pending
exhibit1029036.jpg	Edgar Link	pending
exhibit1029037.jpg	Edgar Link	pending
exhibit1029038.jpg	Edgar Link	pending
exhibit1029039.jpg	Edgar Link	pending
exhibit1029040.jpg	Edgar Link	pending
exhibit1029041.jpg	Edgar Link	pending
exhibit1029042.jpg	Edgar Link	pending
exhibit1029043.jpg	Edgar Link	pending
exhibit1029044.jpg	Edgar Link	pending
exhibit1029045.jpg	Edgar Link	pending
exhibit1029046.jpg	Edgar Link	pending
exhibit1029047.jpg	Edgar Link	pending
exhibit1029048.jpg	Edgar Link	pending
exhibit1029049.jpg	Edgar Link	pending
exhibit1029050.jpg	Edgar Link	pending
exhibit1029051.jpg	Edgar Link	pending
exhibit1029052.jpg	Edgar Link	pending
exhibit1029053.jpg	Edgar Link	pending
exhibit1029054.jpg	Edgar Link	pending
exhibit1029055.jpg	Edgar Link	pending
exhibit1029056.jpg	Edgar Link	pending
exhibit1029057.jpg	Edgar Link	pending
exhibit1029058.jpg	Edgar Link	pending
exhibit1029059.jpg	Edgar Link	pending
exhibit1029060.jpg	Edgar Link	pending
exhibit1029061.jpg	Edgar Link	pending
exhibit1029062.jpg	Edgar Link	pending
exhibit1029063.jpg	Edgar Link	pending
exhibit1029064.jpg	Edgar Link	pending
exhibit1029065.jpg	Edgar Link	pending
exhibit1029066.jpg	Edgar Link	pending
exhibit1029067.jpg	Edgar Link	pending
exhibit1029068.jpg	Edgar Link	pending
exhibit1029069.jpg	Edgar Link	pending
exhibit1029070.jpg	Edgar Link	pending
exhibit1029071.jpg	Edgar Link	pending
exhibit1029072.jpg	Edgar Link	pending
exhibit1029073.jpg	Edgar Link	pending
exhibit1029074.jpg	Edgar Link	pending
exhibit1029075.jpg	Edgar Link	pending
exhibit1029076.jpg	Edgar Link	pending
exhibit1029077.jpg	Edgar Link	pending
exhibit1029078.jpg	Edgar Link	pending
exhibit1029079.jpg	Edgar Link	pending
exhibit1029080.jpg	Edgar Link	pending
exhibit1029081.jpg	Edgar Link	pending
exhibit1029082.jpg	Edgar Link	pending
exhibit1029083.jpg	Edgar Link	pending
exhibit1029084.jpg	Edgar Link	pending
exhibit1029085.jpg	Edgar Link	pending
exhibit1029086.jpg	Edgar Link	pending
exhibit1029087.jpg	Edgar Link	pending
exhibit1029088.jpg	Edgar Link	pending
exhibit1029089.jpg	Edgar Link	pending
exhibit1029090.jpg	Edgar Link	pending
exhibit1029091.jpg	Edgar Link	pending
exhibit1029092.jpg	Edgar Link	pending
exhibit1029093.jpg	Edgar Link	pending
exhibit1029094.jpg	Edgar Link	pending
exhibit1029095.jpg	Edgar Link	pending
exhibit1029096.jpg	Edgar Link	pending
exhibit1029097.jpg	Edgar Link	pending
exhibit1029098.jpg	Edgar Link	pending
exhibit1029099.jpg	Edgar Link	pending
exhibit1029100.jpg	Edgar Link	pending
exhibit1029101.jpg	Edgar Link	pending
exhibit1029102.jpg	Edgar Link	pending
exhibit1029103.jpg	Edgar Link	pending
exhibit1029104.jpg	Edgar Link	pending
exhibit1029105.jpg	Edgar Link	pending
exhibit1029106.jpg	Edgar Link	pending
exhibit1029107.jpg	Edgar Link	pending
exhibit1029108.jpg	Edgar Link	pending
exhibit1029109.jpg	Edgar Link	pending
exhibit1029110.jpg	Edgar Link	pending
exhibit1029111.jpg	Edgar Link	pending
exhibit1029112.jpg	Edgar Link	pending
exhibit1029113.jpg	Edgar Link	pending
exhibit1029114.jpg	Edgar Link	pending
exhibit1036.htm	Edgar Link	pending
exhibit1036001.jpg	Edgar Link	pending
exhibit1036002.jpg	Edgar Link	pending
exhibit1036003.jpg	Edgar Link	pending
exhibit1036004.jpg	Edgar Link	pending
exhibit1036005.jpg	Edgar Link	pending
exhibit1036006.jpg	Edgar Link	pending
exhibit1036007.jpg	Edgar Link	pending
exhibit1036008.jpg	Edgar Link	pending
exhibit1036009.jpg	Edgar Link	pending
exhibit1036010.jpg	Edgar Link	pending
exhibit1036011.jpg	Edgar Link	pending
exhibit1036012.jpg	Edgar Link	pending
exhibit1036013.jpg	Edgar Link	pending
exhibit1036014.jpg	Edgar Link	pending
exhibit1036015.jpg	Edgar Link	pending
exhibit1036016.jpg	Edgar Link	pending
exhibit1036017.jpg	Edgar Link	pending
exhibit1036018.jpg	Edgar Link	pending
exhibit1036019.jpg	Edgar Link	pending
exhibit1036020.jpg	Edgar Link	pending
exhibit1036021.jpg	Edgar Link	pending
exhibit1036022.jpg	Edgar Link	pending
exhibit1036023.jpg	Edgar Link	pending
exhibit1036024.jpg	Edgar Link	pending
exhibit1036025.jpg	Edgar Link	pending
exhibit1036026.jpg	Edgar Link	pending
exhibit1036027.jpg	Edgar Link	pending
exhibit1036028.jpg	Edgar Link	pending
exhibit1036029.jpg	Edgar Link	pending
exhibit1036030.jpg	Edgar Link	pending
exhibit1036031.jpg	Edgar Link	pending
exhibit1036032.jpg	Edgar Link	pending
exhibit1036033.jpg	Edgar Link	pending
exhibit1036034.jpg	Edgar Link	pending
exhibit1036035.jpg	Edgar Link	pending
exhibit1036036.jpg	Edgar Link	pending
exhibit1036037.jpg	Edgar Link	pending
exhibit1036038.jpg	Edgar Link	pending
exhibit1036039.jpg	Edgar Link	pending
exhibit1036040.jpg	Edgar Link	pending
exhibit1036041.jpg	Edgar Link	pending
exhibit1036042.jpg	Edgar Link	pending
exhibit1036043.jpg	Edgar Link	pending
exhibit1036044.jpg	Edgar Link	pending
exhibit1036045.jpg	Edgar Link	pending
exhibit1036046.jpg	Edgar Link	pending
exhibit1036047.jpg	Edgar Link	pending
exhibit1036048.jpg	Edgar Link	pending
exhibit1036049.jpg	Edgar Link	pending
exhibit1036050.jpg	Edgar Link	pending
exhibit1036051.jpg	Edgar Link	pending
exhibit1036052.jpg	Edgar Link	pending
exhibit1036053.jpg	Edgar Link	pending
exhibit1036054.jpg	Edgar Link	pending
exhibit1036055.jpg	Edgar Link	pending
exhibit1036056.jpg	Edgar Link	pending
exhibit211-fy23.htm	Edgar Link	pending
exhibit231.htm	Edgar Link	pending
exhibit311-fy23.htm	Edgar Link	pending
exhibit312-fy23.htm	Edgar Link	pending
exhibit321-fy23.htm	Edgar Link	pending
exhibit322-fy23.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACHR
Archer Aviation Inc. Stock $achr

2023 Q4 Form 10-K Financial Statement

#000162828024007963 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACHR Archer Aviation Inc. Stock $achr

2023 Q4 Form 10-K Financial Statement

#000162828024007963 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACHR
Archer Aviation Inc. Stock $achr